Roche suspends Canadian sales of Tamiflu as demand skyrockets
Faced with soaring demand for Tamiflu--the antiviral drug that can be used to blunt the onslaught of avian flu--Roche has suspended sales of the drug in Canada. Roche said that it is attempting to conserve supplies for the coming flu season and is worried that stockpiles will be depleted before they're truly needed. Governments around the globe have been clamoring for the drug as they prepare for a possible pandemic.
- read this report from Canada.com for more
PLUS: Roche's MabThera demonstrated positive data in Phase III for lymphoma earlier than expected. Article
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
